Objective. Melatonin is a hormone predominantly synthesized and secreted during the night by the pineal gland. Artifi cial light at night, especially its blue part, acutely suppresses the melatonin production. Th e aim of the present study was to fi nd out, whether an intense blue light phototherapy of severe hyperbilirubinemia, may suppress the melatonin production during the night when the eyes will be properly protected by a sleep mask.Methods. Th e main melatonin metabolite, 6-sulphatoxymelatonin was measured in urine in a nine-year old boy suff ering from the Crigler-Najjar syndrome type I. Th e boy was treated during the sleep period with an intense blue light (to 1800 lx) 10 h/day, since his birth. During the phototherapy, his eyes were protected with a sleep mask. Th e concentration of 6-sulphatoxymelatonin was determined in the fi rst morning urine and urine collected aft ernoon during the six days. Th e patient was exposed to phototherapy for three nights, two nights without and the last one with the treatment. Th e control urine samples were obtained from 8 healthy nine-year old boys. Th e level of 6-sulphatoxymelatonin was measured by radioimmunoassay and the data were normalized to urinary creatinine.Results. A distinct melatonin production rhythm was found and 6-sulphatoxymelatonin concentration in urine of the patient was comparable with the values obtained by the control group. No diff erences in 6-sulphatoxymelatonin levels were found between the nights with and without the phototherapy applied.Conclusions. We conclude that the whole night treatment of hyperbilirubinemia with intense blue light has negligible side eff ect on the rhythmic melatonin production, when the eyes are suffi ciently protected by the sleep mask.